Global Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2017 - Product Image

Global Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2017

  • ID: 4377577
  • Report
  • Region: Global
  • Fore Pharma
1 of 3
The latest research, Global Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2017, provides comprehensive insights into Dry Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Dry Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Dry Age-Related Macular Degeneration epidemiology and late stage pipeline.

The report is classified into twelve sections - Dry Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Dry Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Dry Age-Related Macular Degeneration prevalence trends by countries; Dry Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:
  • Dry Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Dry Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Dry Age-Related Macular Degeneration epidemiology: Find out the prevalence of Dry Age-Related Macular Degeneration by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Dry Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Dry Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Dry Age-Related Macular Degeneration market size: Find out the market size for Dry Age-Related Macular Degeneration drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Dry Age-Related Macular Degeneration drug sales: Find out the sales of Dry Age-Related Macular Degeneration drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Dry Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Dry Age-Related Macular Degeneration drugs to 2021 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Dry Age-Related Macular Degeneration market share analysis: Find out the market shares of Dry Age-Related Macular Degeneration drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Dry Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Dry Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Dry Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Dry Age-Related Macular Degeneration: Disease Overview
1.1. Dry Age-Related Macular Degeneration Symptoms
1.2. Dry Age-Related Macular Degeneration Etiology
1.3. Dry Age-Related Macular Degeneration Diagnosis
1.4. Dry Age-Related Macular Degeneration Treatment Options

2. Dry Age-Related Macular Degeneration Pipeline Insights
2.1. Dry Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Dry Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Dry Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Dry Age-Related Macular Degeneration Epidemiology Analysis

4. US Dry Age-Related Macular Degeneration Market Insights
4.1. Marketed Products for Dry Age-Related Macular Degeneration in US
4.2. US Dry Age-Related Macular Degeneration Market Size & Forecast
4.3. US Dry Age-Related Macular Degeneration Product Sales Forecast
4.4. US Dry Age-Related Macular Degeneration Market Share Analysis

5. Germany Dry Age-Related Macular Degeneration Market Insights
5.1. Marketed Products for Dry Age-Related Macular Degeneration in Germany
5.2. Germany Dry Age-Related Macular Degeneration Market Size & Forecast
5.3. Germany Dry Age-Related Macular Degeneration Product Sales Forecast
5.4. Germany Dry Age-Related Macular Degeneration Market Share Analysis

6. France Dry Age-Related Macular Degeneration Market Insights
6.1. Marketed Products for Dry Age-Related Macular Degeneration in France
6.2. France Dry Age-Related Macular Degeneration Market Size & Forecast
6.3. France Dry Age-Related Macular Degeneration Product Sales Forecast
6.4. France Dry Age-Related Macular Degeneration Market Share Analysis

7. Italy Dry Age-Related Macular Degeneration Market Insights
7.1. Marketed Products for Dry Age-Related Macular Degeneration in Italy
7.2. Italy Dry Age-Related Macular Degeneration Market Size & Forecast
7.3. Italy Dry Age-Related Macular Degeneration Product Sales Forecast
7.4. Italy Dry Age-Related Macular Degeneration Market Share Analysis

8. Spain Dry Age-Related Macular Degeneration Market Insights
8.1. Marketed Products for Dry Age-Related Macular Degeneration in Spain
8.2. Spain Dry Age-Related Macular Degeneration Market Size & Forecast
8.3. Spain Dry Age-Related Macular Degeneration Product Sales Forecast
8.4. Spain Dry Age-Related Macular Degeneration Market Share Analysis

9. UK Dry Age-Related Macular Degeneration Market Insights
9.1. Marketed Products for Dry Age-Related Macular Degeneration in UK
9.2. UK Dry Age-Related Macular Degeneration Market Size & Forecast
9.3. UK Dry Age-Related Macular Degeneration Product Sales Forecast
9.4. UK Dry Age-Related Macular Degeneration Market Share Analysis

10. Europe Dry Age-Related Macular Degeneration Market Insights
10.1. Europe Dry Age-Related Macular Degeneration Market Size & Forecast
10.2. Europe Dry Age-Related Macular Degeneration Product Sales Forecast
10.3. Europe Dry Age-Related Macular Degeneration Market Share Analysis

11. Japan Dry Age-Related Macular Degeneration Market Insights
11.1. Marketed Products for Dry Age-Related Macular Degeneration in Japan
11.2. Japan Dry Age-Related Macular Degeneration Market Size & Forecast
11.3. Japan Dry Age-Related Macular Degeneration Product Sales Forecast
11.4. Japan Dry Age-Related Macular Degeneration Market Share Analysis

12. Global Dry Age-Related Macular Degeneration Market Insights
12.1. Global Dry Age-Related Macular Degeneration Market Size & Forecast
12.2. Global Dry Age-Related Macular Degeneration Product Sales Forecast
12.3. Global Dry Age-Related Macular Degeneration Market Share Analysis

13. Research Methodology

List of Tables:
Table 1: Dry Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2017
Table 2: Dry Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2017
Table 3: Dry Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2017
Table 4: Dry Age-Related Macular Degeneration Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Dry Age-Related Macular Degeneration in US, 2017
Table 6: US Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 8: US Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 9: Marketed Products for Dry Age-Related Macular Degeneration in Germany, 2017
Table 10: Germany Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 12: Germany Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 13: Marketed Products for Dry Age-Related Macular Degeneration in France, 2017
Table 14: France Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 16: France Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 17: Marketed Products for Dry Age-Related Macular Degeneration in Italy, 2017
Table 18: Italy Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 20: Italy Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 21: Marketed Products for Dry Age-Related Macular Degeneration in Spain, 2017
Table 22: Spain Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 24: Spain Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 25: Marketed Products for Dry Age-Related Macular Degeneration in UK, 2017
Table 26: UK Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 28: UK Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 29: Europe Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Dry Age-Related Macular Degeneration in Japan, 2017
Table 32: Japan Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 34: Japan Dry Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 35: Global Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Dry Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2017
Figure 2: Dry Age-Related Macular Degeneration Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 4: US Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 5: US Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 6: US Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 7: Germany Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 8: Germany Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 9: Germany Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 10: Germany Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 11: France Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 12: France Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 13: France Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 14: France Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 15: Italy Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 16: Italy Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 17: Italy Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 18: Italy Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 19: Spain Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 20: Spain Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 21: Spain Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 22: Spain Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 23: UK Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 24: UK Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 25: UK Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 26: UK Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 27: Europe Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 28: Europe Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 29: Europe Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 30: Europe Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 31: Japan Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 32: Japan Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 33: Japan Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 34: Japan Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 35: Global Dry Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 36: Global Dry Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 37: Global Dry Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 38: Global Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll